<DOC>
	<DOCNO>NCT01581242</DOCNO>
	<brief_summary>This randomize , open-label , three-sequence , three-period , three-treatment clinical trial investigate pharmacokinetic drug-drug interaction Clevudin Adefovir dipivoxil oral administration healthy male subject .</brief_summary>
	<brief_title>A Clinical Trial Investigate Pharmacokinetic Drug-drug Interaction Clevudine Adefovir Dipivoxil After Oral Administration Healthy Male Subjects</brief_title>
	<detailed_description>To evaluate safety , drug-tolerance , pharmacokinetics Clevudine Adefovir monotherapy Adefovir Clevudine combination healthy male subject</detailed_description>
	<mesh_term>Adefovir</mesh_term>
	<mesh_term>Adefovir dipivoxil</mesh_term>
	<mesh_term>Clevudine</mesh_term>
	<criteria>Age limit 20 45 healthy male subject screen Weight limit 50kg ( 110.23Ib ) 90kg ( 198.41Ib ) BMI 18.526 ( BMI ( kg/m2 ) = weight ( kg ) / { height ( ) } 2 The person fully understand listens clinical trial , receive write consent observe notandum decides participate voluntarily The person past history serious disease liver , kidney , nervous system , respiratory system , gastrointestinal tract system , endocrine system , blood tumor , cardiovascular system , urinary system , mental system clinically The person past history Gastrointestinal operation ( except simple appendectomy herniotomy ) Gastrointestinal system disease ( Chron 's disease , ulcer , acute chronic pancreatitis , etc ) influence absorption clinical drug The person past history hypersensitivity reaction drug contain identical affiliation ingredient ingredient Clevudine , Adefovir dipivoxil others drug ( aspirin , antibiotic etc ) significant past history hypersensitivity reaction clinically The person show result 1.5 time upper limit screen test AST ( SGOT ) , ALT ( SGPT ) The person show result positive HBsAg , HCV Ab , HIV Ab The person past history drug abuse show positive result drug abuse urine drug analysis screen test The person take medication medicine medical supply oriental medicine within 2 week first administration date ' , OTC drug , vitamin supplement health functional food within 1week ( , 's confirm investigator 's judgment affect pharmacokinetics character safety evaluation clinical drug ) The person participate clinical trial within 2 week first administration date ' The person donate plasma pheresis within 1 month first administration date , donate whole blood within 2 month first administration date receive transfusion within month first administration date Persistent drinker ( 21 units/week , 1 unit = 10g pure alcohol ) drinker ca n't stop drink hospitalization period Smoker take drag 10 cigarette per day past three month The person judge unfit participate clinical trial investigator clinical laboratory test result reason</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Clevudine Adefovir dipivoxil</keyword>
	<keyword>pharmacokinetic drug drug interaction</keyword>
	<keyword>oral administration</keyword>
	<keyword>male subject</keyword>
</DOC>